WGRX

Wellgistics Health, Inc. Common Stock
CAPPED RATING

Wellgistics Health, Inc. Common Stock (WGRX) is rated C- (1.9/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Value (C+); its weakest is Profitability (D-).

Quantitative Factor Evaluation • Updated

Overall Rating
1.9 / 5.0
C-
Value
C+
Factor Score 2.7 / 5.0
Growth
D
Factor Score 1.4 / 5.0
Profitability
D-
Factor Score 0.9 / 5.0
Momentum
C+
Factor Score 2.5 / 5.0
Revisions
C-
Factor Score 1.9 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio 0.0
EV / EBITDA 0.0
Rev Growth YoY -85.6%
Gross Margin -49.5%
Price Return 3M N/A
Price Return 12M N/A
Catalyst Signal 0.00
Market Cap N/A
TTM Revenue N/A
Price / Sales 13.0
ROE N/M

Historical Factor Score Progression

Date Value Growth Profitability Momentum Revisions Overall
2026-08-05 C+ (2.7) D (1.4) D- (0.9) C+ (2.5) C- (1.9) C- (1.9)
2026-08-03 C+ (2.7) C- (2.1) D (1.4) C (2.4) C- (2.0) C- (2.1)